Literature DB >> 16099960

HIV/AIDS. Hedged bet: an unusual AIDS vaccine trial.

Jon Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16099960     DOI： 10.1126/science.309.5737.1003

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  3 in total

1.  Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

Authors:  Nia Tatsis; Julie C Fitzgerald; Arturo Reyes-Sandoval; Kimberly C Harris-McCoy; Scott E Hensley; Dongming Zhou; Shih-Wen Lin; Ang Bian; Zhi Quan Xiang; Amaya Iparraguirre; Cesar Lopez-Camacho; E John Wherry; Hildegund C J Ertl
Journal:  Blood       Date:  2007-05-17       Impact factor: 22.113

2.  Adenovirus vectors block human immunodeficiency virus-1 replication in human alveolar macrophages by inhibition of the long terminal repeat.

Authors:  Robert J Kaner; Francisco Santiago; Franck Rahaghi; Elizabeth Michaels; John P Moore; Ronald G Crystal
Journal:  Am J Respir Cell Mol Biol       Date:  2009-10-05       Impact factor: 6.914

3.  CD154 and IL-2 signaling of CD4+ T cells play a critical role in multiple phases of CD8+ CTL responses following adenovirus vaccination.

Authors:  Channakeshava Sokke Umeshappa; Roopa Hebbandi Nanjundappa; Yufeng Xie; Andrew Freywald; Yulin Deng; Hong Ma; Jim Xiang
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.